← Leaderboards
Tylor Robert Lewis
Duke University
$945,130
Attributed
$945,130
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2019–25$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$945,130 · 3
By mechanism
R00$498,000 · 1
K99$252,032 · 1
F32$195,098 · 1
Top collaborators
No co-investigators on record.
Most similar at Duke University
Same institution · by research overlap
- Aravind Asokan$26,081,479
- Sheila A Baker$5,999,116
- Catherine Bowes Rickman$11,208,971
- Glenn Jaffe$4,863,463
- Eric M Darling$2,880,684
Others in their field
Other Emerging Leaders on “Prevent”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$141,293,697
- Kimberly Smith · Ppd Development Lp$115,671,664
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,282,390
- Beth Baseler · Leidos Biomedical Research, Inc.$100,071,064
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
Research focus
PreventAffectMutationPhotoreceptorsRetinal DegenerationTrainingLeadMouse ModelPathologyPhotoreceptor DegenerationProteinsRetinaTherapeutic InterventionRetinitis PigmentosaGenesInsightLightMass Spectrum AnalysisElectroretinographyPathologicBlindnessPhenotypeRetinal DiseasesCareer Development
Grant awards (7)
The role of ADAM9 in retinal health and disease$249,000
R00 · FY2025 · EY · contact PI
The role of ADAM9 in retinal health and disease$249,000
R00 · FY2024 · EY · contact PI
The role of ADAM9 in retinal health and disease$125,988
K99 · FY2023 · EY · contact PI
The role of ADAM9 in retinal health and disease$126,044
K99 · FY2022 · EY · contact PI
Pathological and functional consequences of dimerization-deficient rhodopsin mutations$68,562
F32 · FY2021 · EY · contact PI
Pathological and functional consequences of dimerization-deficient rhodopsin mutations$65,310
F32 · FY2020 · EY · contact PI
Pathological and functional consequences of dimerization-deficient rhodopsin mutations$61,226
F32 · FY2019 · EY · contact PI